Currencies / ANAB
ANAB: AnaptysBio Inc
20.33
USD
0.20
(0.99%)
ANAB exchange rate has changed by 0.99% for today. During the day, the instrument was traded at a low of 19.85 and at a high of 20.50.
Follow AnaptysBio Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANAB News
- AnaptysBio earnings beat by $0.18, revenue topped estimates
- AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
- AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
- Connect Biopharma appoints James A. Schoeneck to board of directors
- AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
- Anaptysbio director Fenton sells $72k in stock
- AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential (NASDAQ:ANAB)
- AnaptysBio: Positive RA Data Bodes Well For Continued Rosnilimab Advancement (NASDAQ:ANAB)
- AnaptysBio Upgraded After RA Drug Matches Top Therapies In Phase 2 Trial - AnaptysBio (NASDAQ:ANAB)
- Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May - AnaptysBio (NASDAQ:ANAB), Asana (NYSE:ASAN)
- This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - AnaptysBio (NASDAQ:ANAB), Blueprint Medicines (NASDAQ:BPMC)
- Stifel analysts reiterate Buy rating for AnaptysBio stock after RA study
- TD Cowen reiterates Buy rating on AnaptysBio stock following updated trial data
- H.C. Wainwright upgrades AnaptysBio stock on positive trial data
- AnaptysBio reports promising Phase 2b trial results for RA drug
- What’s the role of generative AI in drug discovery?
- Market Cap Stock Movers Dominate Wednesday Trading Session
- Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday - AnaptysBio (NASDAQ:ANAB), Abercrombie & Fitch (NYSE:ANF)
- Guggenheim raises AnaptysBio stock target to $90, maintains Buy
- Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
- Wolfe Research maintains Outperform on AnaptysBio shares, $25 target
- Crude Oil Gains 1%; US Composite PMI Surges In March - AnaptysBio (NASDAQ:ANAB), AZEK Co (NYSE:AZEK)
- Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - AnaptysBio (NASDAQ:ANAB), AZEK Co (NYSE:AZEK)
- UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - AnaptysBio (NASDAQ:ANAB), American Eagle Outfitters (NYSE:AEO)
Daily Range
19.85
20.50
Year Range
12.22
40.70
- Previous Close
- 20.13
- Open
- 20.10
- Bid
- 20.33
- Ask
- 20.63
- Low
- 19.85
- High
- 20.50
- Volume
- 1.088 K
- Daily Change
- 0.99%
- Month Change
- -16.82%
- 6 Months Change
- 20.15%
- Year Change
- -46.20%
31 August, Sunday